Arthritis Northwest, Rheumatology

Spokane, Washington 99204

0 studies enrolling now · 13 studies all time

What they study most

Active Psoriatic Arthritis, Arthritis, Rheumatoid, Axial Spondyloarthritis, Lupus Erythematosus, Systemic, Psoriatic Arthritis, Rheumatoid Arthritis, Spondyloarthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) — Completed
• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis — Completed
• Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis — Stopped early
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis — Completed
• A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis — Completed
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus — Stopped early
• A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) — Completed
• Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
• A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01 — Stopped early